Giant Cell Arteritis
GCA, Takayasu’s and polyarteritis nodosa: Implementing ACR guidelines
ATLANTA — A panel at ACR/ARP 2019 offered an overview of the new guidelines for giant cell arteritis, Takayasu’s syndrome, and polyarteritis nodosa.
Giant cell arteritis incidence similar among black, white patients
Contrary to widespread belief that biopsy-proven giant cell arteritis is comparatively rare among black patients, researchers found the condition occurs at a similar rate among black and white patients, according to data published in JAMA Ophthalmology.
Giant Cell Arteritis with John Stone, MD
In this episode, John Stone, MD, MPH, director of clinical rheumatology at Massachusetts General Hospital, sits down to discuss his approach to giant cell arteritis and the results of the GiACTA trial. Learn why Stone believes the most important diagnostic test in GCA is the patient’s history.
Giant Cell Arteritis with Leonard Calabrese, DO
Leonard Calabrese, DO, details the clinical manifestations of giant cell arteritis, the complex scenarios rheumatologists face when working with GCA, and the pathogenesis of this disease. Calabrese also shares clinical pearls and tips for success.